Richard Jelsma, MD
Orthopedic Surgery · Sherman, TXNPI 1962494419
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,972 of the $4,833 with a category attached, or 61.5%. Pylant Medical accounts for 61.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $1,618 and has fallen 89.7% since, to $167 in 2024.
Across 25 payments — averaging $193.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$3K
- Stryker$2K
- Zimmer Biomet$210
- Pacira Pharmaceuticals Incorporated$83
- Smith+Nephew$20
- Johnson & Johnson$18
Across 1 payment — averaging $885,925 each. An ownership or investment interest held by the physician or an immediate family member.
- Zurimed Technologies Inc.$886K
What the payments were for
- Travel & lodging$1,16024%
- Food & beverage$70115%
- Education$2,97261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 6 | $2,988 |
| Stryker | 12 | $1,514 |
| Zimmer Biomet | 4 | $210 |
| Pacira Pharmaceuticals Incorporated | 1 | $83 |
| Smith+Nephew | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,833 in reported general payments places this provider in the 65th percentile of 33 orthopedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 188 | $1,519 |
| Meloxicam | 82 | $230 |
| Tramadol Hcl | 25 | $80 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Sherman
- Steven BrotzmanAustin$336K
- Rajesh ArakalPlano$79K
- Mark ScioliLubbock$70K
- John SimsAmarillo$35K
- Katherine LiHouston$19K
- Jason RamseyLubbock$13K
- Michael MarkowitzPlano$13K
- Mark GreenbergIrving$9K
- Bradley HarmanCleburne$7K
- David TemplinNew Braunfels$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.